Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Takeda recalls eye drug Natpara but warns patients not to abruptly stop treatment
Takeda Pharmaceutical’s been looking for a buyer for Natpara to provide some debt relief, but it has just run into some complicating circumstances.
Vertex spends nearly $1bn on Semma's unproven diabetes cell tech
It is now up to Vertex to make a success of the group’s technology, which involves using a device to allow the implantation of pancreatic islet cells in the hope of curing type 1 diabetes.
Trump Administration Announces $1.8 Billion in Funding to States to Continue Combating Opioid Crisis
Today, the U.
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report
In the 1980s, only 4% of new drugs approved by the FDA were cancer treatments.
UTA scientist explores using nanoparticles to reduce size of deep-seated tumors
Another collaborative project from a nanoparticles expert at The University of Texas at Arlington has yielded promising results in the search for more effective, targeted cancer treatments.
Tuberculosis mutation discovery paves way for better treatments
PNAS publishes Rutgers New Jersey Medical school study.
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
SOUTH SAN FRANCISCO, Calif.
Israeli researchers develop antibacterial coating for implants to prevent infections
JERUSALEM, Sept.
FDA Singles Out 9 More Drug Substances Not for Compounding
FDA Singles Out 9 More Drug Substances Not for CompoundingFollowing a court win late last month to keep one such drug substance out of the hands of compounders, the US Food and Drug Administration ...
Allergan : Receives FDA Approval of Juvederm VOLUMA XC for Mid-Face Injection via Cannula
DUBLIN - Allergan plc (NYSE.
'Daily' cocaine use changes genes in the brain and fuels addiction, study finds
Chronic cocaine use could alter genes in your brain and contribute to addiction, a new study finds.
A blood test could predict heart disease and early death risks 40 YEARS in advance, study suggests
A blood test for signs of inflammation in young people may predict their risks of heart disease and an early death, a new study suggests.
374
375
376
377
378
379
380
381
382
